M2care and ZEISS Ventures Support Maculaser Oy to Advance Pioneering Temperature-Controlled Retinal Laser Therapy
Appointment of M2care’s Florence Thueux and ZEISS Ventures’ Mike Gänßler to Maculaser Board of Directors Press release Helsinki, Finland / Lyon, France / Oberkochen,
3 September 2025
M2care secures €26 million from the FTA2 fund managed by BPI France
Healthtech venture studio M2care raises €26 million to accelerate the creation and development of innovative healthcare projects Paris, 03 September 2025 – M2care, a
26 August 2025
Rhovica secures CHF 2.3M and nominates Carsten Laue as Board Member
Rhovica secure CHF 2.3M with M2care, Kickfund, Valuemaker and BAs and nominate Carsten Laue as board member.
21 February 2025
SEPSI Score: promising results from the retrospective study
The results of the retrospective study show that SEPSI Score analyzes in real-time more than 150 parameters per patient
17 December 2024
M2care raises 20 millions euros
M2care, a venture studio dedicated to Healthtech, raises €20M to accelerate the creation and development of 8 innovative projects. Paris / Lyon / Aix
10 December 2024
Inserm Transfert and M2care sign partnership agreement
M2care and Inserm Transfert announce the signing of a strategic alliance aimed at supporting the development of medical technologies and the creation of innovative
